Targeting allograft inflammatory factor 1 reprograms kidney macrophages to enhance repair
Journal of Clinical Investigation · 03.03.2025 · 135 (5)
DOI: 10.1172/jci185146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 21.01.2025. Verfasst von Irma Husain und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, and. Hauptthemen laut MEDLINE: Macrophages, Calcium-Binding Proteins, Reperfusion Injury, Kidney. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, ASN, NIH,.
Abstract (Originalsprache)
The role of macrophages (MΦs) remains incompletely understood in kidney injury and repair. The plasticity of MΦs offers an opportunity to polarize them toward mediating injury resolution in both native and transplanted kidneys undergoing ischemia and/or rejection. Here, we show that infiltrating kidney MΦs augmented their own allograft inflammatory factor 1 (AIF-1) expression after injury. Aif1 genetic deletion led to MΦ polarization toward a reparative phenotype while halting the development of kidney fibrosis. The enhanced repair was mediated by higher levels of antiinflammatory and proregenerative markers, leading to a reduction in cell death and an increase in proliferation of kidney tubular epithelial cells after ischemia followed by reperfusion injury (I/RI). Adoptive transfer of Aif1 –/– MΦs into Aif1 +/+ mice conferred protection against I/RI. Conversely, depletion of MΦs reversed the tissue-reparative effects in Aif1 –/– mice. We further demonstrated increased expression of AIF-1 in human kidney biopsies from native kidneys with acute kidney injury or chronic kidney disease, as well as in biopsies from kidney allografts undergoing acute or chronic rejection. We conclude that AIF-1 is a MΦ marker of renal inflammation, and its targeting uncouples MΦ reparative functions from profibrotic functions. Thus, therapies inhibiting AIF-1 when ischemic injury is inevitable have the potential to reduce the global burden of kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, and.
- Duke Transplant Center, Duke University School of Medicine, Durham, North Carolina, USA.
- Department of Biomedical Engineering, Duke University Pratt School of Engineering, Durham, North Carolina, USA.
- Department of Pathology.
- Department of Anaesthesiology.
- Department of Mechanical Engineering and Materials Science, and.
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- ASN, NIH,
Zitieren
APA
Husain, I., Shah, H., Jordan, C. Z., Natesh, N. R., Fay, O. K., Chen, Y., Privratsky, J. R., Kitai, H., Souma, T., Varghese, S., Howell, D. N., Thorp, E. B., & Luo, X. (2025). Targeting allograft inflammatory factor 1 reprograms kidney macrophages to enhance repair. Journal of Clinical Investigation, 135(5). https://doi.org/10.1172/jci185146
Vancouver
Husain I, Shah H, Jordan CZ, Natesh NR, Fay OK, Chen Y, et al. Targeting allograft inflammatory factor 1 reprograms kidney macrophages to enhance repair. Journal of Clinical Investigation. 2025;135(5). doi:10.1172/jci185146
BibTeX
@article{Husain2025,
author = {Husain, Irma and Shah, Holly and Jordan, Collin Z and Natesh, Naveen R and Fay, Olivia K and Chen, Yanting and Privratsky, Jamie R and Kitai, Hiroki and Souma, Tomokazu and Varghese, Shyni and Howell, David N and Thorp, Edward B and Luo, Xunrong},
title = {Targeting allograft inflammatory factor 1 reprograms kidney macrophages to enhance repair},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {5},
doi = {10.1172/jci185146}
}
EUVIMED